No Data
No Data
Driven by the weak yen, the consumer spending of tourists visiting Japan in the first 9 months has reached a new high.
①Driven by the weakness of the Japanese yen, Japan's tourism industry is extremely hot in 2024; ②Data shows that as of September, international tourists spent 5.86 trillion yen in Japan (equivalent to 39.27 billion US dollars); ③This exceeded the consumption record of 5.3 trillion yen set for the full year of 2023.
Value HR and other [buy demand for next week]
[Next week's buying demand (table)] Code; Stock; Stock Price Impact; Buy Demand; Credit Multiple; Closing Price; Day-over-day Comparison <1399>; Listed Volatility; 20357%; 14250; 0.02; 2220.5; -13.5 <2530>; MXSA180; 1690%; 169; 4.57; 31040; -7000 <6078>; Value HR; 731%; 242700; 0.09; 1741; -6 <3747>; Intertray; 688%; 29600; 20.46; 3
Hamee Corp Unveils Recycled Plastic Fashion Accessories
OpenAI has raised 6.6 billion dollars.
OpenAI has reportedly secured $6.6 billion (approximately 960 billion yen) in its latest funding round. The company's valuation is estimated at $157 billion. It is reported that the company's efforts to build world-class technology in the field of artificial intelligence (AI) will be further strengthened.
Stocks that moved the previous day include INTLOOP, Management Solutions, and Eternal Hospitality Group, among others.
Stock name <Code> 17th closing price⇒Day-on-day comparison Cosel <6905> 1026 -144 Operating profit in the first quarter decreased by 72.0%. Hamee <3134> 1037 -94 Operating profit in the first quarter increased by 28.3%, but the progress rate towards the full-year financial estimates remains at 10.7%. Modalis <4883> 122 +30 The method of treating muscular dystrophy targeting the DMPK gene has been patented in Japan. INTLOOP <9556> 4080 +700 Operating profit for the fiscal year ending July 2025
Active and newly established stocks in the afternoon session.
*Cosel<6905> 1026 -144 First-quarter operating profit decreased by 72.0%. *Hamee<3134> 1037 -94 First-quarter operating profit increased by 28.3%, but the progress rate for the full-year forecast remains at 10.7%. *Modalis<4883> 122 +30 "Treatment method for muscular dystrophy targeting the DMPK gene" receives patent evaluation in Japan. *INTLOOP<9556> 4080 +700 25 July year operating profit expected to increase by 30.7% in the medium term.
No Data
No Data